The data indicated that RASSF1A methylation has the potential to be useful in differentiating between SCLC and NSCLC, as SCLC exhibited a considerably higher level of methylation compared to NSCLC (p<0.001). The gene discussed is RASSF1; the disease is non-small cell lung carcinoma.